News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine

    adminFebruary 26, 202201.8k views

    Synopsis : Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies Sanofi and GlaxoSmithKline (GSK) have announced that…

    Read more

    CHMP provides initial assessment of Valneva’s COVID-19 vaccine

    adminFebruary 26, 202201.8k views

    Summary : The Committee for Medicinal Products for Human Use (CHMP) has provided an initial assessment of Valneva’s inactivated, adjuvanted COVID-19 vaccine…

    Read more

    KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma

    adminFebruary 26, 202201.8k views

    Summary : MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare…

    Read more

    Eli Lilly Diabetes Drug Notches Another Win in Competitive Space

    adminFebruary 26, 202201.7k views

    Summary : One of Eli Lilly’s diabetes drugs just scored another win with the U.S. Food and Drug Administration to expand its…

    Read more

    FDA Adjusts EUA Dosing On Evusheld To Fight Omicron

    adminFebruary 26, 202201.7k views

    Summary: The U.S. Food and Drug Administration (FDA) has revised its emergency use authorization (EUA) for AstraZeneca’s Evusheld to a higher dose…

    Read more

    AbbVie Makes Moves to Increase Profits in 2022

    adminFebruary 26, 202202.1k views

    Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will…

    Read more

    Approval of Purdue’s Opioid Reversal Drug Gets Mixed Reviews

    adminFebruary 26, 202201.7k views

    Summary:  The U.S. Food and Drug Administration has approved the use of Purdue Pharma’s candidate injectable treatment for partially or completely reversing…

    Read more

    Moderna Projects COVID-19 Vaccine Sales at $19 Billion for 2022

    adminFebruary 25, 202202.1k views

    Summary : Moderna only has a single marketed product, but it’s a blockbuster, for now at least. That product is the company’s…

    Read more

    US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021

    adminFebruary 25, 202201.9k views

    Summary : The success of mRNA vaccines against COVID-19 has become a cash cow for Moderna, the Pfizer and BioNTech team and…

    Read more

    Research Collab Uncovers Underlying Mechanism for ALS and Dementia

    adminFebruary 25, 202201.8k views

    Summary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants…

    Read more

    Posts navigation

    1 … 36 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top